Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.

Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.

Performance of fluorescence polarisation immunoassay reagents for carbamazepine, phenytoin, phenobarbitone, primidone, and valproic acid on a Cobas Fara II analyser.

Valproic acid-phenytoin interaction.

Prediction of unbound serum valproic acid concentration by using in vivo binding parameters.

The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.

Effect of influenza vaccination on plasma phenytoin concentrations.

The effect of storage conditions on salivary cortisol concentrations using an enzyme immunoassay.

Decreased plasma protein binding of phenytoin in patients on valproic acid.

An enzyme immunoassay for determining plasma concentrations of didemnin B.

Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.

Measurement of phenytoin in serum using in-house reagents employing the Syva enzyme-multiplied immunoassay technique principle.

Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Modification of phenytoin clearance by valproic acid in normal subjects.

Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients.

Enzyme immunoassay for plasma estradiol using a monoclonal antibody.

Effect of memantine on plasma concentrations of carbamazepine and phenytoin in rats: A controlled experimental study.

Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Hyperammonemia associated with valproic acid concentrations.

Effect of valproic acid on hepatic function.

Effect of intake on fasting heat production, respiratory quotient and plasma metabolites measured using the washed rumen technique.

Getting the MAX out of Computational Models: The Prediction of Unbound-Brain and Unbound-Plasma Maximum Concentrations.

In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation.

Enzyme-labelled immunoassay for plasma cortisol.

The effect of phenytoin on the tissue concentrations of digoxin in the rat.

Suggest Documents

Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.

Performance of fluorescence polarisation immunoassay reagents for carbamazepine, phenytoin, phenobarbitone, primidone, and valproic acid on a Cobas Fara II analyser.

Valproic acid-phenytoin interaction.

Prediction of unbound serum valproic acid concentration by using in vivo binding parameters.

The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.

Effect of influenza vaccination on plasma phenytoin concentrations.

The effect of storage conditions on salivary cortisol concentrations using an enzyme immunoassay.

Decreased plasma protein binding of phenytoin in patients on valproic acid.

An enzyme immunoassay for determining plasma concentrations of didemnin B.

Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.

Measurement of phenytoin in serum using in-house reagents employing the Syva enzyme-multiplied immunoassay technique principle.

Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Modification of phenytoin clearance by valproic acid in normal subjects.

Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients.

Enzyme immunoassay for plasma estradiol using a monoclonal antibody.

Effect of memantine on plasma concentrations of carbamazepine and phenytoin in rats: A controlled experimental study.

Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Hyperammonemia associated with valproic acid concentrations.

Effect of valproic acid on hepatic function.

Effect of intake on fasting heat production, respiratory quotient and plasma metabolites measured using the washed rumen technique.

Getting the MAX out of Computational Models: The Prediction of Unbound-Brain and Unbound-Plasma Maximum Concentrations.

In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation.

Enzyme-labelled immunoassay for plasma cortisol.

The effect of phenytoin on the tissue concentrations of digoxin in the rat.

Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.

Recommend Documents

Follow Us